Treating Impaired Cognition in Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|8|1587-1594

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.8, 2012-06, pp. : 1587-1594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Herbal medicine improves cognition in schizophrenia

By  

Inpharma, Vol. 1, Iss. 1658, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Anticholinergics linked to impaired cognition in older adults

By  

Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Preattentional and attentional cognitive deficits as targets for treating schizophrenia

By Braff David   Light Gregory  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite

Treating schizophrenia: changes in attitudes, compliance, prescribing

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 290, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Muscarinic Receptors as a Target for Drugs Treating Schizophrenia

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 163-181

Bentham Science Publishers

Access to resources Recommend Favorite